{"id":1681,"date":"2009-02-01T12:09:00","date_gmt":"2009-02-01T11:09:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2009\/leserbrief-26"},"modified":"2009-02-01T12:09:00","modified_gmt":"2009-02-01T11:09:00","slug":"leserbrief-26","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2009\/leserbrief-26","title":{"rendered":"Leserbrief"},"content":{"rendered":"<p>Routinem\u00e4\u00dfiger Einsatz von Fosfomycin? Frage von Apotheker Dr. H.K. aus Coesfeld: >> Gibt es nach Ihrer Kenntnis neue Empfehlungen, die Fosfomycin (Infectofos\u00ae, Monuril\u00ae) st\u00e4rker in den therapeutischen Blick r\u00fccken lassen und einen routinem\u00e4\u00dfigen Einsatz, z.B. bei septischen Zust\u00e4nden, empfehlenswert scheinen lassen? Fosfomycin wurde initial 1969 aus Kulturen von Streptomyces spec. gewonnen (1). In den folgenden [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Routinem\u00e4\u00dfiger Einsatz von Fosfomycin? Frage von Apotheker Dr. H.K. aus Coesfeld: >> Gibt es nach Ihrer Kenntnis neue Empfehlungen, die Fosfomycin (Infectofos\u00ae, Monuril\u00ae) st\u00e4rker in den therapeutischen Blick r\u00fccken lassen und einen routinem\u00e4\u00dfigen Einsatz, z.B. bei septischen Zust\u00e4nden, empfehlenswert scheinen lassen? Fosfomycin wurde initial 1969 aus Kulturen von Streptomyces spec. gewonnen (1). In den folgenden [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[2203,2599],"class_list":["post-1681","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-fosfomycin","tag-sepsis"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1681","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1681"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1681\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1681"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1681"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}